Non-antigen-contacting region of an asymmetric bispecific antibody to factors IXa/X significantly affects factor VIII-mimetic activity.
about
Emerging and future therapies for hemophiliaMutational landscape of antibody variable domains reveals a switch modulating the interdomain conformational dynamics and antigen binding.Antibodies to watch in 2017Tethered-variable CL bispecific IgG: an antibody platform for rapid bispecific antibody screening.The Potential Close Future of Hemophilia Treatment - Gene Therapy, TFPI Inhibition, Antithrombin Silencing, and Mimicking Factor VIII with an Engineered Antibody.
P2860
Non-antigen-contacting region of an asymmetric bispecific antibody to factors IXa/X significantly affects factor VIII-mimetic activity.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Non-antigen-contacting region ...... factor VIII-mimetic activity.
@en
Non-antigen-contacting region ...... factor VIII-mimetic activity.
@nl
type
label
Non-antigen-contacting region ...... factor VIII-mimetic activity.
@en
Non-antigen-contacting region ...... factor VIII-mimetic activity.
@nl
prefLabel
Non-antigen-contacting region ...... factor VIII-mimetic activity.
@en
Non-antigen-contacting region ...... factor VIII-mimetic activity.
@nl
P2093
P2860
P1476
Non-antigen-contacting region ...... s factor VIII-mimetic activity
@en
P2093
Atsushi Muto
Kazutaka Yoshihashi
Kunihiro Hattori
Miho Funaki
Takehisa Kitazawa
Tetsuhiro Soeda
Tetsuo Kojima
Tomoyuki Igawa
P2860
P304
P356
10.4161/19420862.2015.989028
P577
2015-01-01T00:00:00Z